Despite its market success, MIT45 has faced significant scrutiny:
High-potency variants, such as Super K Extra Strong , which reportedly contains over 300mg of mitragynine per bottle—equivalent to dozens of standard kratom capsules. Despite its market success, MIT45 has faced significant
As of March 2024, the company has been the subject of a civil class action lawsuit alleging misleading sales practices and failure to disclose that kratom's active ingredients act on the same receptors as opioids, carrying risks of addiction and withdrawal. Despite its market success